Cross-institution positioning
Jul 29, 2026Mixed positioning. 2 accumulating, 2 exited across 4 comparable institutions.
Source: Schedule 13 researchSee how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.
Mixed positioning. 2 accumulating, 2 exited across 4 comparable institutions.
Source: Schedule 13 research2 increased/new, 0 reduced/exited across 2 managers in the latest comparable Form 13F quarter.
Source: Form 13F quarter-end holdingsOver the last 90 days, SEC-coded non-derivative P/S activity includes 0 purchases by 0 reporting owners and 3 sales by 1 reporting owner. Amendments are shown in the filing evidence but excluded from rolling activity totals.
Source: SEC Forms 3/4/53 non-amendment material events in the last 90 days; Latest classified evidence: Results of operations / financial condition. Registration and prospectus filings are treated as financing capacity/disclosure evidence, not proof that securities were sold.
Source: SEC 8-K / securities filing metadataNet income +16.4% YoY; Free cash flow -1.7% YoY. Periods are compared only when the SEC facts are aligned and comparable.
Source: SEC Company FactsRecent close is 13% through its reported 52-week range; -44.0% over one year.
Source: Stored historical price seriesFiled Jul 29, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.
Premium research values are withheld until unlocked.
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
See each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
Comparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Compare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
Reported Section 16 ownership activity. Rolling purchase/sale totals use non-derivative SEC transaction codes P and S only; amendments remain visible but are excluded from those totals.
| Date | Reporting owner | Code | Security | Shares | Price | Ownership | Filed |
|---|---|---|---|---|---|---|---|
| Sep 22, 2026 | DEMILIO MARK S | SOpen-market or private sale | Common Stock | 1.0K | $132.00 | Indirect | Sep 24, 2026 |
| Jul 10, 2026 | DEMILIO MARK S | SOpen-market or private sale | Common Stock | 1.1K | $169.00 | Indirect | Jul 13, 2026 |
| Jul 10, 2026 | DEMILIO MARK S | SOpen-market or private sale | Common Stock | 1.3K | $167.95 | Indirect | Jul 13, 2026 |
| Apr 14, 2026 | DEMILIO MARK S | AGrant, award, or other acquisition | Common Stock | 13.0K | $0.00 | Direct | Apr 16, 2026 |
| Apr 14, 2026 | Chi Lisa | AGrant, award, or other acquisition · derivative | Stock Option (Right to Buy) | 30.0K | $0.00 | Direct | Apr 16, 2026 |
| Apr 14, 2026 | Chaya Eri | AGrant, award, or other acquisition · derivative | Stock Option (Right to Buy) | 40.0K | $0.00 | Direct | Apr 16, 2026 |
| Apr 14, 2026 | Hargarten Christina | AGrant, award, or other acquisition · derivative | Stock Option (Right to Buy) | 7.5K | $0.00 | Direct | Apr 16, 2026 |
| Apr 14, 2026 | Preston Jack M | AGrant, award, or other acquisition · derivative | Stock Option (Right to Buy) | 25.0K | $0.00 | Direct | Apr 16, 2026 |
| Apr 6, 2026 | Chaya Eri | MExercise or conversion of derivative · derivative · amendment | Stock Option (Right to Buy) | 25.0K | $0.00 | Direct | Apr 9, 2026 |
| Apr 6, 2026 | Chaya Eri | MExercise or conversion of derivative · amendment | Common Stock | 25.0K | $39.42 | Indirect | Apr 9, 2026 |
| Apr 5, 2026 | Chaya Eri | AGrant, award, or other acquisition · derivative | Stock Option (Right to Buy) | 1.0K | $0.00 | Direct | Apr 7, 2026 |
| Mar 31, 2026 | Chaya Eri | MExercise or conversion of derivative · derivative | Stock Option (Right to Buy) | 11.0K | $0.00 | Direct | Apr 1, 2026 |
| Mar 31, 2026 | Chaya Eri | SOpen-market or private sale | Common Stock | 1.7K | $140.02 | Direct | Apr 1, 2026 |
| Mar 31, 2026 | Chaya Eri | SOpen-market or private sale | Common Stock | 2.9K | $139.38 | Direct | Apr 1, 2026 |
| Mar 31, 2026 | Chaya Eri | SOpen-market or private sale | Common Stock | 1.7K | $138.21 | Direct | Apr 1, 2026 |
| Mar 31, 2026 | Chaya Eri | SOpen-market or private sale | Common Stock | 1.6K | $137.04 | Direct | Apr 1, 2026 |
| Mar 31, 2026 | Chaya Eri | SOpen-market or private sale | Common Stock | 2.0K | $135.93 | Direct | Apr 1, 2026 |
| Mar 31, 2026 | Chaya Eri | SOpen-market or private sale | Common Stock | 1.1K | $135.27 | Direct | Apr 1, 2026 |
| Mar 31, 2026 | Chaya Eri | MExercise or conversion of derivative | Common Stock | 11.0K | $39.42 | Direct | Apr 1, 2026 |
| Mar 30, 2026 | Hargarten Christina | MExercise or conversion of derivative · derivative | Restricted Stock Unit (RSU) | 1.1K | $0.00 | Direct | Apr 1, 2026 |
Recent 8-K item classifications plus securities registration and prospectus filings. Registration or prospectus filings show financing capacity/disclosure activity; they do not by themselves prove that securities were sold.
| Filed | Form | 8-K item(s) | Classification | Capital context | SEC |
|---|---|---|---|---|---|
| Sep 10, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Jul 23, 2026 | 8-K | 7.01, 9.01 | Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Jul 8, 2026 | 8-K | 7.01, 9.01 | Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Jun 25, 2026 | 8-K | 5.07 | Shareholder vote results | — | Filing |
| Jun 11, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.
Dated price context from the historical market series already collected for this security.
Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| BlackRock CIK0002012383 | Jun 30, 2026 observed Jul 29, 2026 filed · 29d Schedule 13G amendment | Earliest Schedule 13G amendment found | 1.9M | 9.90% | $164.73 | $176.14 | $116.99 |
| Vanguard Group CIK0000102909 | Mar 13, 2026 observed Mar 27, 2026 filed · 14d Schedule 13G amendment | Exit below reporting threshold | 0 -1.4M | 0.00% -7.69 pts | $128.37 | $130.85 | $116.99 |
| Fidelity / FMR CIK0000315066 | Nov 12, 2024 observed Nov 12, 2024 filed · 0d Schedule 13G amendment | Reported accumulation | 2.8M +893.3K | 15.00% +4.69 pts | $333.43 | $333.43 | $116.99 |
Compare RH with other securities showing similar institutional activity or recent accumulation across several tracked institutions.